# Fate Therapeutics Inc: Form 8-K, filed Aug 4, 2021

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: 8-K
- Filed: 2021-08-04
- Accepted by EDGAR: Aug 4, 2021, 16:05 ET
- Period: 2021-08-04
- Accession: 0001564590-21-040793
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000156459021040793/fate-8k_20210804.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000156459021040793/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000156459021040793/fate-8k_20210804.htm

Filed Aug 4, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-040793. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
